Serko Limited — Director's Dealing 2020

Feb 6, 2020

==> picture [117 x 32] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		Serko Limited
Date this disclosure made:		07-Jan-20
Date of last disclosure:		10-Jan-20
Director or senior manager giving disclosure
Full name(s):		Simon Botherway
Name of listed issuer:		Serko Limited
Name of related body corporate (if applicable):		Not applicable
Position held in listed issuer:		Director
Summary of acquisition or disposal of relevant interest(excluding specified derivatives)
Class of affected quoted financial products:		Ordinary shares
Nature of the affected relevant interest(s):		Beneficial owner of ordinary shares held in custody for Simon Botherway pursuant to Non-Executive Director Fixed Trading Plan
For that relevant interest-
Number held in class before acquisition or disposal:		30,096.16
Number held in class after acquisition or disposal:		30,879.40
Current registered holder(s):		Unknown
Registered holder(s) once transfers are registered:		Custodian Services Limited as custodian fo Simon Botherway
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:		1
Details of transactions requiring disclosure-
Date of transaction:		4-Feb-20
Nature of transaction:		On market purchase of shares pursuant to the Non-Executive Director Fixed Trading Plan
Name of any other party or parties to the transaction (if known):		Unknown
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:		$3,994.47 ($5.10/share)
Number of financialproducts to which the transaction related:		783.23
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period:		Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during t closed period:		Not applicable
Date of the prior written clearance (if any):		Not applicable
Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest: For that relevant interest,-
		Ordinary shares
		Registered holder and beneficial holder

Number held in class:		1. Registered holder and beneficial owner
		of 284,909 shares
		2. Registered holder and beneficial owner
		of 884,091 shares by virtue of being a
		trustee of the Arrow Trust and having the
		power to exercise a right to vote attached
		to, and to dispose of, the Arrow Trust
		Shares
Current registered holder(s):		1. Simon Botherway
		2. Simon Botherway and MSH Trustee
		(Arrow) Limited as trustees of the Arrow
		Trust
For a derivative relevant interest,-
Type of derivative:		Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if		Not applicable
any):
A statement as to whether the derivative is cash settled or physically settled:		Not applicable
Maturity date of the derivative (if any):		Not applicable
Expiry date of the derivative (if any):		Not applicable
The price's specified terms (if any):		Not applicable
Any other details needed to understand how the amount of the consideration payable under the		Not applicable
derivative or the value of the derivative is affected by the value of the underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:		Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in		Not applicable
derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer:

Date of signature:

06-Jan-20